{"id":3328,"date":"2025-04-10T10:20:35","date_gmt":"2025-04-10T10:20:35","guid":{"rendered":"https:\/\/visionranking.com\/wegovita\/?page_id=3328"},"modified":"2025-04-15T09:23:10","modified_gmt":"2025-04-15T09:23:10","slug":"management-plan-for-stage-ii-liver-cancer-tace-approach","status":"publish","type":"page","link":"https:\/\/visionranking.com\/wegovita\/management-plan-for-stage-ii-liver-cancer-tace-approach\/","title":{"rendered":"Management Plan for Stage II Liver Cancer \u2013 TACE Approach"},"content":{"rendered":"\t\t
\n\t\t\t\t\r\n
\n\t\t
\n\t\t\r\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
All Treatments Services<\/a><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Contact Us<\/a><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

1. Initial Consultation & Evaluation<\/h4>
  • Comprehensive assessment by a hepatobiliary surgeon and interventional radiologist.<\/li>
  • Review of medical history, liver function, and overall health status.<\/li>
  • Discussion of treatment options, including TACE and potential surgical intervention if feasible.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
    \n\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    2. Medical Records Review & Pre-Treatment Assessment<\/h4>
    • Detailed analysis of prior imaging, laboratory tests, and treatment history.<\/li>
    • Evaluation of liver function using\u00a0Child-Pugh Score and ALBI score<\/strong>\u00a0to assess treatment tolerance.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
      \n\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t

      3. Laboratory Investigations<\/h4>
      • Complete blood count (CBC)<\/li>
      • Liver function tests (LFTs)<\/li>
      • Renal function panel<\/li>
      • Coagulation profile<\/li>
      • Tumor markers (Alpha-Fetoprotein \u2013 AFP)<\/li>
      • Hepatitis B and C serology (if applicable)<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
        \n\t\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t

        4. Pre-Treatment Imaging<\/h4>
        • Contrast-enhanced CT scan or MRI<\/strong>\u00a0of the liver to assess tumor size, vascular invasion, and suitability for TACE.<\/li>
        • Angiographic assessment<\/strong>\u00a0to map hepatic artery anatomy.<\/li>
        • Additional PET scan<\/strong>\u00a0if metastatic disease is suspected.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
          \n\t\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t\t\t\t\t\t

          5. Multidisciplinary Tumor Board Discussion<\/h4>

          Case review by a team of hepatobiliary surgeons, interventional radiologists, and oncologists.<\/p>

          Decision on treatment strategy:<\/h5>
          • TACE as primary treatment\u00a0<\/strong>(if surgery is not feasible).<\/li>
          • TACE as neoadjuvant therapy\u00a0<\/strong>(prior to surgery or liver transplantation).<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
            \n\t\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            6. Pre-TACE Preparation<\/h4>
            • Patient education regarding the procedure, risks, and expected outcomes.<\/li>
            • Pre-procedure hydration\u00a0<\/strong>and renal function optimization.<\/li>
            • Antibiotic prophylaxis if required.<\/li>
            • Temporary discontinuation of anticoagulants if applicable.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
              \n\t\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t\t\t\t\t

              7. Transarterial Chemoembolization (TACE) Procedure<\/h4>
              • Patient transferred to the interventional radiology suite.<\/strong><\/li>
              • Local anesthesia with conscious sedation\u00a0<\/strong>or general anesthesia if indicated.<\/li>
              • Catheter insertion via femoral artery<\/strong>, advanced into the hepatic artery.<\/li>
              • Selective embolization of tumor-feeding arteries\u00a0<\/strong>using chemotherapy (individual selection of chemotherapy) mixed with embolic agents.<\/li>
              • Post-procedure angiography<\/strong>\u00a0to confirm successful embolization.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
                \n\t\t\t\t\t
                \n\t\t\t\t
                \n\t\t\t\t
                \n\t\t\t\t\t\t\t\t\t

                8. Immediate Post-TACE Monitoring<\/h4>
                • Patient observed in the\u00a0post-procedure recovery unit<\/strong>\u00a0for 4\u20136 hours.<\/li>
                • Pain management with\u00a0analgesics<\/strong>\u00a0and antiemetics for post-embolization syndrome.<\/li>
                • Monitoring of vital signs, liver enzymes, and kidney function.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
                  \n\t\t\t\t\t
                  \n\t\t\t\t
                  \n\t\t\t\t
                  \n\t\t\t\t\t\t\t\t\t

                  9. Hospital Stay & Recovery<\/h4>
                  • Observation for 24\u201348 hours<\/strong>\u00a0if needed, especially in patients with compromised liver function.<\/li>
                  • Gradual resumption of diet and mobility.<\/li>
                  • Post-TACE syndrome management<\/strong>\u00a0(fever, nausea, right upper quadrant pain).<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
                    \n\t\t\t\t\t
                    \n\t\t\t\t
                    \n\t\t\t\t
                    \n\t\t\t\t\t\t\t\t\t

                    10. Follow-Up & Response Assessment<\/h4>
                    • First imaging follow-up (CT\/MRI) in 4\u20136 weeks<\/strong>\u00a0to assess tumor response.<\/li>
                    • Repeat AFP measurement\u00a0<\/strong>to monitor treatment effectiveness.<\/li>
                    • Consider repeat TACE<\/strong>\u00a0if incomplete tumor response.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
                      \n\t\t\t\t\t
                      \n\t\t\t\t
                      \n\t\t\t\t
                      \n\t\t\t\t\t\t\t\t\t

                      11. Long-Term Monitoring & Next Steps<\/h4>
                      • Regular imaging every 3 months to assess for recurrence or progression.<\/li>
                      • Evaluation for\u00a0surgical resection or liver transplantation<\/strong>\u00a0if tumor burden is reduced.<\/li>
                      • Discussion of\u00a0systemic therapy<\/strong>\u00a0(e.g., tyrosine kinase inhibitors like sorafenib) if disease progresses.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

                        All Treatments Services Contact Us 1. Initial Consultation & Evaluation Comprehensive assessment by a hepatobiliary surgeon and interventional radiologist. Review of medical history, liver function, and overall health status. Discussion of treatment options, including TACE and potential surgical intervention if feasible. 2. Medical Records Review & Pre-Treatment Assessment Detailed analysis of prior imaging, laboratory tests,…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3328","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/pages\/3328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/comments?post=3328"}],"version-history":[{"count":34,"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/pages\/3328\/revisions"}],"predecessor-version":[{"id":3488,"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/pages\/3328\/revisions\/3488"}],"wp:attachment":[{"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/media?parent=3328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}